<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu Y</submitter><funding>Zaozhuang University</funding><funding>Natural Science Foundation of Shandong Province</funding><pagination>E5660</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6888404</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(22)</volume><pubmed_abstract>The development of Pt(IV) anticancer prodrugs to overcome the detrimental side effects of Pt(II)-based anticancer drugs is of current interest. The kinetics and reaction mechanisms of the reductive activation of the carboplatin Pt(IV) prodrug cis,trans-[Pt(cbdca)(NH3)2Cl2] (cbdca = cyclobutane-1,1-dicarboxylate) by the major small-molecule reductants in human plasma were analyzed in this work. The reductants included ascorbate (Asc), the thiol-containing molecules L-cysteine (Cys), DL-homocysteine (Hcy), and glutathione (GSH), and the dipeptide Cys-Gly. Overall second-order kinetics were established in all cases. At the physiological pH of 7.4, the observed second-order rate constants k' followed the order Asc &lt;&lt; Cys-Gly ~ Hcy &lt; GSH &lt; Cys. This reactivity order together with the abundances</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Investigations of the Kinetics and Mechanism of Reduction of a Carboplatin Pt(IV) Prodrug by the Major Small-Molecule Reductants in Human Plasma.</pubmed_title><pmcid>PMC6888404</pmcid><funding_grant_id>1020717</funding_grant_id><funding_grant_id>ZR2019MB015</funding_grant_id><funding_grant_id>2018BS060</funding_grant_id><pubmed_authors>Xu L</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Zhou L</pubmed_authors><pubmed_authors>Elding LI</pubmed_authors><pubmed_authors>Tian H</pubmed_authors><pubmed_authors>Xu B</pubmed_authors><pubmed_authors>Shi T</pubmed_authors><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>Wang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Investigations of the Kinetics and Mechanism of Reduction of a Carboplatin Pt(IV) Prodrug by the Major Small-Molecule Reductants in Human Plasma.</name><description>The development of Pt(IV) anticancer prodrugs to overcome the detrimental side effects of Pt(II)-based anticancer drugs is of current interest. The kinetics and reaction mechanisms of the reductive activation of the carboplatin Pt(IV) prodrug cis,trans-[Pt(cbdca)(NH3)2Cl2] (cbdca = cyclobutane-1,1-dicarboxylate) by the major small-molecule reductants in human plasma were analyzed in this work. The reductants included ascorbate (Asc), the thiol-containing molecules L-cysteine (Cys), DL-homocysteine (Hcy), and glutathione (GSH), and the dipeptide Cys-Gly. Overall second-order kinetics were established in all cases. At the physiological pH of 7.4, the observed second-order rate constants k' followed the order Asc &lt;&lt; Cys-Gly ~ Hcy &lt; GSH &lt; Cys. This reactivity order together with the abundances</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Nov</publication><modification>2025-04-05T15:09:22.777Z</modification><creation>2020-05-21T21:20:36Z</creation></dates><accession>S-EPMC6888404</accession><cross_references><pubmed>31726728</pubmed><doi>10.3390/ijms20225660</doi></cross_references></HashMap>